
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AL(L) | 3,158 | 77.2% | -1.91 | 842 | 75.7% |
| AL(R) | 929 | 22.7% | -1.84 | 260 | 23.4% |
| CentralBrain-unspecified | 6 | 0.1% | 0.87 | 11 | 1.0% |
| upstream partner | # | NT | conns v2LN5 | % In | CV |
|---|---|---|---|---|---|
| ORN_VM6v | 32 | ACh | 1,124 | 73.3% | 0.6 |
| ORN_VM6m | 18 | ACh | 59.5 | 3.9% | 0.8 |
| vLN29 (L) | 1 | unc | 58.5 | 3.8% | 0.0 |
| vLN28 (L) | 1 | Glu | 48 | 3.1% | 0.0 |
| v2LN5 (L) | 2 | ACh | 36 | 2.3% | 0.1 |
| lLN2T_a (L) | 3 | ACh | 26 | 1.7% | 0.6 |
| v2LN5 (R) | 1 | ACh | 24 | 1.6% | 0.0 |
| lLN2X04 (L) | 2 | ACh | 22.5 | 1.5% | 0.1 |
| VM6_adPN (L) | 1 | ACh | 21 | 1.4% | 0.0 |
| ALIN7 (R) | 1 | GABA | 17 | 1.1% | 0.0 |
| il3LN6 (L) | 1 | GABA | 8.5 | 0.6% | 0.0 |
| v2LN32 (L) | 1 | Glu | 8 | 0.5% | 0.0 |
| il3LN6 (R) | 1 | GABA | 8 | 0.5% | 0.0 |
| lLN2R_a (L) | 2 | GABA | 5.5 | 0.4% | 0.1 |
| lLN2F_a (L) | 2 | unc | 5 | 0.3% | 0.8 |
| v2LN33 (L) | 2 | ACh | 5 | 0.3% | 0.4 |
| lLN2X12 (L) | 4 | ACh | 4.5 | 0.3% | 0.5 |
| lLN2X11 (L) | 2 | ACh | 4 | 0.3% | 0.5 |
| vLN28 (R) | 1 | Glu | 2.5 | 0.2% | 0.0 |
| OA-VUMa5 (M) | 2 | OA | 2.5 | 0.2% | 0.6 |
| lLN1_bc (L) | 3 | ACh | 2.5 | 0.2% | 0.3 |
| v2LN31 (L) | 1 | unc | 2 | 0.1% | 0.0 |
| v2LN30 (L) | 1 | unc | 2 | 0.1% | 0.0 |
| vLN27 (L) | 1 | unc | 2 | 0.1% | 0.0 |
| CSD (R) | 1 | 5-HT | 2 | 0.1% | 0.0 |
| HRN_VP1d | 3 | ACh | 2 | 0.1% | 0.4 |
| v2LN38 (L) | 2 | ACh | 2 | 0.1% | 0.5 |
| VM6_adPN (R) | 1 | ACh | 1.5 | 0.1% | 0.0 |
| ORN_VM4 | 1 | ACh | 1.5 | 0.1% | 0.0 |
| v2LN33 (R) | 1 | ACh | 1.5 | 0.1% | 0.0 |
| VP1m+VP2_lvPN2 (L) | 2 | ACh | 1.5 | 0.1% | 0.3 |
| lLN2P_c (L) | 1 | GABA | 1.5 | 0.1% | 0.0 |
| ORN_VM6l | 1 | ACh | 1 | 0.1% | 0.0 |
| M_lPNm11A (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| ALIN5 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| v2LN4 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| v2LN49 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| VP1d_il2PN (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| VP2+VC5_l2PN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| ALBN1 (R) | 1 | unc | 1 | 0.1% | 0.0 |
| lLN2F_b (L) | 2 | GABA | 1 | 0.1% | 0.0 |
| lLN2X02 (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| CB4083 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| AVLP447 (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| M_l2PNm15 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| v2LN32 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| lLN2P_a (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| v2LN3A (L) | 1 | unc | 0.5 | 0.0% | 0.0 |
| VP1d_il2PN (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| M_l2PN10t19 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| v2LN31 (R) | 1 | unc | 0.5 | 0.0% | 0.0 |
| vLN29 (R) | 1 | unc | 0.5 | 0.0% | 0.0 |
| M_l2PN10t19 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| vLN25 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| lLN2X11 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| v2LN42 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| v2LNX01 (L) | 1 | unc | 0.5 | 0.0% | 0.0 |
| ALBN1 (L) | 1 | unc | 0.5 | 0.0% | 0.0 |
| ALIN3 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| CB1545 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| CB3417 (L) | 1 | unc | 0.5 | 0.0% | 0.0 |
| VP2_l2PN (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| v2LN42 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| lLN2P_b (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| vLN24 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 0.5 | 0.0% | 0.0 |
| lLN2T_e (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| downstream partner | # | NT | conns v2LN5 | % Out | CV |
|---|---|---|---|---|---|
| VP1d_il2PN (R) | 1 | ACh | 153 | 13.3% | 0.0 |
| VP1d_il2PN (L) | 1 | ACh | 150 | 13.0% | 0.0 |
| M_l2PN10t19 (L) | 2 | ACh | 144.5 | 12.5% | 1.0 |
| M_l2PN10t19 (R) | 2 | ACh | 101.5 | 8.8% | 1.0 |
| vLN27 (L) | 1 | unc | 95.5 | 8.3% | 0.0 |
| vLN28 (L) | 1 | Glu | 49.5 | 4.3% | 0.0 |
| VM6_adPN (R) | 1 | ACh | 43 | 3.7% | 0.0 |
| v2LN33 (L) | 2 | ACh | 42.5 | 3.7% | 0.2 |
| v2LN31 (R) | 1 | unc | 41 | 3.6% | 0.0 |
| v2LN5 (L) | 2 | ACh | 36 | 3.1% | 0.1 |
| vLN29 (L) | 1 | unc | 34.5 | 3.0% | 0.0 |
| VM6_adPN (L) | 1 | ACh | 32.5 | 2.8% | 0.0 |
| v2LN5 (R) | 1 | ACh | 27.5 | 2.4% | 0.0 |
| vLN27 (R) | 1 | unc | 22 | 1.9% | 0.0 |
| v2LN38 (R) | 2 | ACh | 21 | 1.8% | 0.7 |
| v2LN31 (L) | 1 | unc | 19.5 | 1.7% | 0.0 |
| v2LN33 (R) | 2 | ACh | 18.5 | 1.6% | 0.8 |
| v2LN38 (L) | 2 | ACh | 13 | 1.1% | 0.9 |
| CSD (R) | 1 | 5-HT | 10 | 0.9% | 0.0 |
| ORN_VM6v | 13 | ACh | 9.5 | 0.8% | 0.5 |
| CB3447 (L) | 2 | GABA | 7.5 | 0.7% | 0.7 |
| vLN28 (R) | 1 | Glu | 6 | 0.5% | 0.0 |
| M_l2PN3t18 (L) | 1 | ACh | 3.5 | 0.3% | 0.0 |
| VP2+VC5_l2PN (L) | 1 | ACh | 3.5 | 0.3% | 0.0 |
| vLN29 (R) | 1 | unc | 3.5 | 0.3% | 0.0 |
| lLN2R_a (L) | 3 | GABA | 3.5 | 0.3% | 0.2 |
| M_lPNm11A (L) | 1 | ACh | 2.5 | 0.2% | 0.0 |
| VM6_lvPN (R) | 2 | ACh | 2.5 | 0.2% | 0.6 |
| lLN2P_c (L) | 2 | GABA | 2.5 | 0.2% | 0.6 |
| CB1048 (L) | 2 | Glu | 2.5 | 0.2% | 0.6 |
| VM6_lvPN (L) | 3 | ACh | 2.5 | 0.2% | 0.3 |
| v2LN42 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| vLN24 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| il3LN6 (R) | 1 | GABA | 2 | 0.2% | 0.0 |
| vLN25 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| lLN2X04 (L) | 2 | ACh | 2 | 0.2% | 0.0 |
| VP2_adPN (L) | 1 | ACh | 1.5 | 0.1% | 0.0 |
| v2LN34A (L) | 1 | Glu | 1.5 | 0.1% | 0.0 |
| VP2+VC5_l2PN (R) | 1 | ACh | 1.5 | 0.1% | 0.0 |
| lLN2T_e (L) | 1 | ACh | 1.5 | 0.1% | 0.0 |
| lLN2T_a (L) | 2 | ACh | 1.5 | 0.1% | 0.3 |
| CB3417 (L) | 2 | unc | 1.5 | 0.1% | 0.3 |
| lLN1_bc (L) | 2 | ACh | 1.5 | 0.1% | 0.3 |
| lLN2X11 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| il3LN6 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| v2LN42 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| M_l2PNl23 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| M_spPN4t9 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| M_vPNml60 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| lLN2X05 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| M_l2PNl20 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| HRN_VP1d | 2 | ACh | 1 | 0.1% | 0.0 |
| VP3+_l2PN (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| l2LN20 (R) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| ORN_VM6m | 1 | ACh | 0.5 | 0.0% | 0.0 |
| ORN_VM1 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| l2LN20 (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| M_lPNm11D (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| M_lvPNm46 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| CB0650 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| lLN2P_b (R) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| v2LN50 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| M_lPNm11B (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| v2LN4 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| ALIN3 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| VP5+Z_adPN (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| M_spPN4t9 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| VM1_lPN (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| ALIN5 (R) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| ALBN1 (R) | 1 | unc | 0.5 | 0.0% | 0.0 |
| MZ_lv2PN (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| lLN2F_b (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| TRN_VP2 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| v2LN36 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| CB3383 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| CB3326 (L) | 1 | unc | 0.5 | 0.0% | 0.0 |
| v2LN34F (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| M_lPNm11A (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| M_adPNm3 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| M_lvPNm48 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| M_lv2PN9t49_b (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| lLN2T_b (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| VM1_lPN (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| OA-VUMa5 (M) | 1 | OA | 0.5 | 0.0% | 0.0 |
| lLN1_a (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| M_l2PNl20 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| lLN2F_a (L) | 1 | unc | 0.5 | 0.0% | 0.0 |
| V_ilPN (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |